Fortress Biotech, Inc.
FBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001429260
No open-market purchases or sales by Fortress Biotech, Inc. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $17.7M in total; no superinvestor holds it.
Other share classesFBIOP
Q4 2024 vs. Q3 2024
How the institutions holding Fortress Biotech, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 50 | 53 | +3 |
| Shares | 4.45M | 4.82M | +370.5K (+8.3%) |
| Value | $6.43M | $9.77M | +$3.35M (+52.1%) |
New holders (11)
Institutions that held Fortress Biotech, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kestra Advisory Services, LLC | 226,231 | $458.1K | 0.00% |
| Two Sigma Investments, LP | 54,054 | $109.5K | 0.00% |
| Jane Street Group, LLC | 34,159 | $69.2K | 0.00% |
| XTX Topco Ltd | 30,619 | $62.0K | 0.01% |
| Wolverine Trading, LLC | 12,156 | $26.5K | 0.00% |
| Goldman Sachs Group Inc | 12,837 | $26.0K | 0.00% |
| UBS Group AG | 11,821 | $23.9K | 0.00% |
| SBI Securities Co., Ltd. | 5,098 | $10.3K | 0.00% |
| Ameriflex Group, Inc. | 4,400 | $8.01K | 0.00% |
| R Squared Ltd | 1,380 | $2.79K | 0.00% |
| Marshall & Sterling Wealth Advisors Inc. | 460 | $932 | 0.00% |
Sold out (8)
Institutions that held Fortress Biotech, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Rosalind Advisors, Inc. | 502,828 | $726.6K |
| Millennium Management LLC | 17,151 | $24.8K |
| Gladstone Institutional Advisory LLC | 15,000 | $21.7K |
| SeaCrest Wealth Management, LLC | 12,000 | $17.3K |
| Russell Investments Group, Ltd. | 2,080 | $3.00K |
| Federated Hermes, Inc. | 263 | $380 |
| Newbridge Financial Services Group, Inc. | 133 | $192 |
| Danske Bank A/S | 3 | $4 |